| 08:00 - 12:15 |
Plenary Session II |
Theme: Building bridges: Networks of excellence
Chairs: Simon Agwale (DCCC) / Peter Smith (PB) |
| Key-note addresses : |
| 08:00 - 08:20 |
Dr Coumba Toure - African AIDS Vaccine Programme (AAVP) |
| 08:20 - 08:40 |
Prof. Fred Binka - Malaria Clinical Trials Alliance (MCTA) |
| 08:40 - 09:00 |
Prof. Andrew Nunn - Microbicides Network |
| 09:00 - 09:20 |
Dr Christian Lienhardt - International Union against TB and Lung Disease (IUATLD) _ TB networks of trialists |
| 09:20 - 09:40 |
Prof. Wen Kilama - African Malaria Network Trust (AMANET) |
| 09:40 - 10:00 |
Dr Abraham Aseffa - Pan-African Bioethics Network (PABIN) |
| 10:00 - 10:30 |
Dr Christa Janko - The Vienna School Capacity Building Network for Africa |
| 10:30 - 13:00 |
Coffee break / electronic poster sessions |
| 13:00 - 14:00 |
Lunch |
| 14:00 - 17:00 |
Parallel sessions II: Capacity building in Africa
Presentations and facilitated discussions |
Room A: HIV/AIDS
Facilitator/Rapporteur: Michel Klein (PB) / Walter Jaoko (DCCC) |
| 14:00 - 14:05 |
Introductory remark by the facilitator |
| 14:05 - 14:25 |
Dr Abraham Alabi
Development and evaluation of high throughput, cheap and reliable assays for monitoring HIV-1 and HIV-2 viral loads in ARV programmes and clinical trials in developing countries |
| 14:25 - 14:45 |
Dr Didier Ekouevi
Preventing per-partum transmission of HIV-1 in Afroca: tenofovir based alternatives to single dose nevirapine in the light of future treatment options |
| 15:05 - 15:25 |
Dr Bornwell Sikateyo
An assessment of the understanding of the informed consent process by participants in microbicide intervention trials in Zambia |
| 15:25 - 15:55 |
Tea break |
| 15:55 - 16:15 |
Dr William Kilembe
Preparations for HIV Vaccine Research at Zambia Emory HIV Research Project (ZEHRP) |
| 16:15 - 16:35 |
Dr Modest Mulenga
Challenges of expediting the conduct of ethically approved phase II and III clinical trials on herbal medications in Africa |
| 16:35 - 17:00 |
General discussion |
Room B: Malaria
Facilitator/Rapporteur: Peter Kremsner (PB)/ Mathieu Ndounga (DCCC) |
| 14:00 - 14:05 |
Introductory remark by the facilitator |
| 14:05 - 14:25 |
Dr Abdoulaye Djimde
Assessment of the Public Health Benefit of artemisin based combination therapies for uncomplicated malaria treatment in Mali |
| 14:25 - 11:45 |
Dr Alexis Nzila
Understanding the mechanism of piperaquine resistance |
| 14:45 - 15:05 |
Ms Leah Mwai
Understanding the mechanism of resistance to lumefantrine by Plasmodium falciparum |
| 15:05 - 15:25 |
Dr Charles Arama
Host immunigenetic factors involved in the susceptibility to malaria in sympatric ethnic groups (Dogon and Fulani) in Mali |
| 15:25 - 15:55 |
Tea break |
| 15:55 - 16:15 |
Dr Andrew Kitua
Capacity building for malaria research: Tanzanian experience |
| 16:15 - 16:35 |
Dr Exnevia Gomo
Research management strengthening in an emerging medical education institution: experiences of the research support centre, College of Medicine, Malawi |
| 16:35 - 17:00 |
General discussion |
Room C: Tuberculosis
Facilitator/Rapporteur: Laura Brum (ENNP) / Michael Makanga (EDCTP SEC) |
| 14:00 - 14:05 |
Introductory remark by the facilitator |
| 14:05 - 14:25 |
Prof. Maoiwa Mukthar
The burden of tuberculosis in eastern Sudan: epidemiology and drug resistance patterns of Mycobacterium tuberculosis isolates |
| 14:25 - 11:45 |
Dr Willem Hanekom
BCG-induced immune correlates of protection against tuberculosis |
| 14:45 - 15:05 |
Dr Thuli Mthiyane
Reconstitution of TB antigen specific IFN-y responses in TB-HIV co-infected participants |
| 15:05 - 15:25 |
Dr Getnet Yimer Ali
Anti tuberculosis - anti Retroviral drugs induced hepatotoxicity and introduction of these drugs at the level of CYP 450 metabolism |
| 15:25 - 15:55 |
Tea break |
| 15:55 - 16:15 |
Dr Christo van Nierkerk
Clinical site and laboratory assessment project |
| 16:15 - 16:35 |
Dr Ashley Veldman
An alternative consenting process: appropriate for developing countries? |
| 16:35 - 17:00 |
General discussion |